10.73
price down icon2.45%   -0.27
after-market 시간 외 거래: 10.59 -0.14 -1.30%
loading

CorMedix Inc 주식(CRMD)의 최신 뉴스

pulisher
Oct 10, 2025

Is CorMedix Inc. stock reversal real or fakeWeekly Market Report & Capital Efficiency Focused Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Backtesting results for CorMedix Inc. trading strategiesJuly 2025 Drop Watch & Accurate Intraday Trading Signals - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

CorMedix: Challenging Long-Term Risk-Reward, Maintain Sell - Seeking Alpha

Oct 09, 2025
pulisher
Oct 09, 2025

Analyzing recovery setups for CorMedix Inc. investorsEntry Point & Fast Moving Market Watchlists - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Is CorMedix Inc. a candidate for recovery play2025 Historical Comparison & Consistent Growth Stock Picks - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Risk adjusted return profile for CorMedix Inc. analyzedJuly 2025 Spike Watch & Safe Entry Point Identification - newser.com

Oct 09, 2025
pulisher
Oct 07, 2025

Will CorMedix's DefenCath Edge Last If Bigger Heparin Rivals Close In? - sharewise.com

Oct 07, 2025
pulisher
Oct 06, 2025

How cyclical is CorMedix Inc. (19KA) stock compared to rivalsJobs Report & Verified Swing Trading Watchlist - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Why CorMedix Inc. stock is in analyst buy zone2025 Institutional Moves & Consistent Profit Trade Alerts - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

CorMedix (CRMD): Assessing Valuation Following Phase III REZZAYO Trial Enrollment and Melinta Growth Moves - Sahm

Oct 05, 2025
pulisher
Oct 05, 2025

What analysts say about CorMedix Inc stockMoving Average Crossovers & Low Cost Market Strategies - earlytimes.in

Oct 05, 2025
pulisher
Oct 05, 2025

Is a relief rally coming for CorMedix Inc. holders2025 Earnings Impact & Accurate Intraday Trading Signals - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Will CorMedix Inc. (19KA) stock benefit from Fed rate cutsJuly 2025 Final Week & Risk Managed Investment Signals - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

ANGO Stock Gains Following Q1 Earnings Beat, Gross Margin Improves - The Globe and Mail

Oct 03, 2025
pulisher
Oct 03, 2025

CorMedix (CRMD): Assessing Valuation After Recent Volatility and Analyst Price Targets - Yahoo Finance

Oct 03, 2025
pulisher
Oct 03, 2025

What macro factors could drive CorMedix Inc. (19KA) stock higherJuly 2025 Weekly Recap & Free Daily Entry Point Trade Alerts - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Is it too late to sell CorMedix Inc.Trade Signal Summary & Expert Verified Stock Movement Alerts - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Real time scanner hits for CorMedix Inc. explainedCEO Change & Free Community Consensus Stock Picks - newser.com

Oct 02, 2025
pulisher
Oct 01, 2025

Is CorMedix Inc. building a consolidation baseDividend Hike & Smart Allocation Stock Reports - newser.com

Oct 01, 2025
pulisher
Sep 30, 2025

CorMedix files to sell 6.32M shares of common stock for holders - MSN

Sep 30, 2025
pulisher
Sep 30, 2025

CorMedix Bets Big On Melinta In $300 Million Deal - Finimize

Sep 30, 2025
pulisher
Sep 30, 2025

CorMedix completes enrollment in phase III fungal infection study By Investing.com - Investing.com Nigeria

Sep 30, 2025
pulisher
Sep 29, 2025

Cormedix announces completion of enrollment in phase III Respect clinical trial for Rezzayo - MarketScreener

Sep 29, 2025
pulisher
Sep 29, 2025

CorMedix completes enrollment in phase III fungal infection study - Investing.com

Sep 29, 2025
pulisher
Sep 29, 2025

Cormedix Announces Completion Of Enrollment In Phase Iii Respect Clinical Trial For Rezzayo - TradingView

Sep 29, 2025
pulisher
Sep 29, 2025

CorMedix Inc. Completes Enrollment in Phase III ReSPECT Study for REZZAYO® in Fungal Infection Prophylaxis, Topline Results Expected 2Q 2026 - Quiver Quantitative

Sep 29, 2025
pulisher
Sep 29, 2025

CorMedix Announces Completion of Enrollment in Phase III ReSPECT Clinical Trial for REZZAYO - Yahoo Finance

Sep 29, 2025
pulisher
Sep 29, 2025

Major Clinical Trial Progress: CorMedix's REZZAYO Could Transform Blood and Marrow Transplant Care - Stock Titan

Sep 29, 2025
pulisher
Sep 28, 2025

What drives CorMedix Inc stock priceSector ETF Performance & Unlock Smart Investment Tactics That Work - earlytimes.in

Sep 28, 2025
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
자본화:     |  볼륨(24시간):